Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesare Gridelli

Showing results (171-180 of 357) with videos related to

Pageof 36
Sort By:
Current Medicinal Chemistry|November 19, 2016
The Role of the Antiangiogenetic Ramucirumab in the Treatment of Advanced Non Small Cell Lung CancerPaolo Maione, Assunta Sgambato, Francesca Casaluce, et al.
Current Pharmaceutical Design|July 30, 2015
New Antiangiogenetic Therapy Beyond Bevacizumab in the Treatment of Advanced Non Small Cell Lung CancerPaola Claudia Sacco, Paolo Maione, Antonio Rossi, et al.
Expert Review of Respiratory Medicine|March 24, 2015
Necitumumab for the treatment of stage IV metastatic squamous non-small-cell lung cancerPaola Claudia Sacco, Paolo Maione, Antonio Rossi, et al.
Frontiers in Oncology|August 8, 2022
Incorporating atezolizumab in the adjuvant setting of non-small cell lung cancer: key discussion points from an expert multidisciplinary panel by Italian Association of Thoracic OncologyFilippo de Marinis, Ilaria Attili, Cesare Gridelli, et al.
Clinical Lung Cancer|October 1, 2008
New targeted therapies and small-cell lung cancerAntonio Rossi, Paolo Maione, Giovanni Palazzolo, et al.
Lung Cancer (Amsterdam, Netherlands)|December 23, 2023
Face to face among different chemo-immunotherapy combinations in the first line treatment of patients with advanced non-small cell lung cancer: Results of an international expert panel meeting by the italian association of thoracic oncology (AIOT)Cesare Gridelli, Solange Peters, Tony Mok, et al.
Journal of Thoracic Disease|January 21, 2012
Treatment of advanced non small cell lung cancerMaria Anna Bareschino, Clorinda Schettino, Antonio Rossi, et al.
Clinical Lung Cancer|May 21, 2015
Treatment of Unfit Patients With Advanced Non-Small-Cell Lung Cancer: Definition Criteria According an Expert PanelFilippo De Marinis, Emilio Bria, Paul Baas, et al.
The Oncologist|October 9, 2010
Future scenarios for the treatment of advanced non-small cell lung cancer: focus on taxane-containing regimensFrancesco Grossi, Kaoru Kubota, Federico Cappuzzo, et al.
Expert Opinion on Drug Safety|January 26, 2011
Pemetrexed in advanced non-small cell lung cancerCesare Gridelli, Paolo Maione, Antonio Rossi, et al.
Pageof 36

Showing results (171-180 of 357) with videos related to

Sort By:
Pageof 36
Current Medicinal Chemistry|November 19, 2016
The Role of the Antiangiogenetic Ramucirumab in the Treatment of Advanced Non Small Cell Lung CancerPaolo Maione, Assunta Sgambato, Francesca Casaluce, et al.
Current Pharmaceutical Design|July 30, 2015
New Antiangiogenetic Therapy Beyond Bevacizumab in the Treatment of Advanced Non Small Cell Lung CancerPaola Claudia Sacco, Paolo Maione, Antonio Rossi, et al.
Expert Review of Respiratory Medicine|March 24, 2015
Necitumumab for the treatment of stage IV metastatic squamous non-small-cell lung cancerPaola Claudia Sacco, Paolo Maione, Antonio Rossi, et al.
Frontiers in Oncology|August 8, 2022
Incorporating atezolizumab in the adjuvant setting of non-small cell lung cancer: key discussion points from an expert multidisciplinary panel by Italian Association of Thoracic OncologyFilippo de Marinis, Ilaria Attili, Cesare Gridelli, et al.
Clinical Lung Cancer|October 1, 2008
New targeted therapies and small-cell lung cancerAntonio Rossi, Paolo Maione, Giovanni Palazzolo, et al.
Lung Cancer (Amsterdam, Netherlands)|December 23, 2023
Face to face among different chemo-immunotherapy combinations in the first line treatment of patients with advanced non-small cell lung cancer: Results of an international expert panel meeting by the italian association of thoracic oncology (AIOT)Cesare Gridelli, Solange Peters, Tony Mok, et al.
Journal of Thoracic Disease|January 21, 2012
Treatment of advanced non small cell lung cancerMaria Anna Bareschino, Clorinda Schettino, Antonio Rossi, et al.
Clinical Lung Cancer|May 21, 2015
Treatment of Unfit Patients With Advanced Non-Small-Cell Lung Cancer: Definition Criteria According an Expert PanelFilippo De Marinis, Emilio Bria, Paul Baas, et al.
The Oncologist|October 9, 2010
Future scenarios for the treatment of advanced non-small cell lung cancer: focus on taxane-containing regimensFrancesco Grossi, Kaoru Kubota, Federico Cappuzzo, et al.
Expert Opinion on Drug Safety|January 26, 2011
Pemetrexed in advanced non-small cell lung cancerCesare Gridelli, Paolo Maione, Antonio Rossi, et al.
Pageof 36